Monday, March 24, 2014 8:43:17 PM
GC (and his team..lets give credit to all working in the decision making process here). We are a preclinical stage company; WS wont assign a significant market cap until SERIOUS progress is made....like getting an IND filed, moving LymPro forward to the goal line, starting up the Phase IIb Eltoprazine trial or any partnership or licensing deal is announced...or the Uplisting is finalized.
The PPS is a pressure cooker right now; but one day soon the lid will be blown off...all the ingredients were added to the recipe recently with the LPC financing deal, added more talent to the management and operations teams... and the addition of the Eltoprazine compound (possible 2-3 distinct indications there alone)...need a spark and KABOOM!!!!
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM